Dr Reddy’s Labs Q4 Results: Cons PAT jumps 22% to Rs 1,594 crore; Rs 8 per share dividend announced

Dr Reddy’s Labs Q4 Results: Dr Reddy’s Laboratories on Friday reported a consolidated net profit growth of 22% to Rs 1,594 crore in Q4FY25 versus Rs 1,307 crore reported in the year ago period.

© 2024 Investment-solutions.co | All Rights Reserved
Disclaimer: Investment-solutions.co offers evaluations, insights, and reports on financial markets and investment products. We do not provide brokerage services nor can we promise specific financial outcomes. Every investment carries risk, including the potential loss of invested capital. The material on this website is intended for informational use only and should not be interpreted as professional financial advice. Outcomes may differ, and it’s important to seek guidance from a licensed financial advisor before making any investment decisions.

Risk Warning
Trading in financial markets, including currencies, carries a high level of risk and may result in the loss of your capital. Price fluctuations may occur due to factors such as market volatility, regulatory updates, or political events. Past performance is not a reliable indicator of future results.

Content Usage Restrictions
No portion of this website or its materials may be copied, shared, or distributed in any manner without express written consent from Investment-solutions.co.

Generated by Feedzy